Table 2.

Univariate analysis of factors associated with 90-day readmission in veterans with IBD

Item	No readmission	90-day readmission	P value
Age (year, x ± s)	59.2 ± 15.6	61.4 ± 13.1	0.31
Male (n (%))	138 (96.5)	59 (100)	0.15
Caucasian (n (%))	128 (89.5)	57 (96.6)	0.10
History of psychiatric disorder (n (%))	74 (51.7)	42 (71.2)	0.01
Type of IBD (n (%))			< 0.001
Crohn’s disease	78 (54.5)	48 (81.4)
Ulcerative colitis	65 (45.5)	11 (18.6)
Duration of IBD (year, median(IQR))	16 (7-30)	16 (3-34)	0.84
History of bowel resection (n (%))	95 (66.4)	39 (66.1)	0.96
IBD medication prior to admission (n (%))
5-ASA	51 (35.7)	15 (25.4)	0.16
Immunomodulator (AZA/6-MP or MTX)	29 (20.3)	15 (25.4)	0.42
Anti-TNF	18 (12.6)	6 (10.2)	0.63
Steroids	25 (17.5)	15 (25.4)	0.20
Psychiatric/pain medication prior to admission (n (%))
Benzodiazepine	24 (16.8)	9 (15.3)	0.79
Narcotics	57 (39.9)	28 (47.5)	0.32
Antidepressant	47 (32.9)	33 (55.9)	0.002
Medication at discharge (n (%))
Change in IBD medication at discharge	32 (22.4)	23 (39)	0.02
Benzodiazepine at discharge	22 (15.4)	8 (13.6)	0.74
Narcotics at discharge	75 (52.4)	29 (49.2)	0.67
Discharge to home (n (%))	135 (94.4)	51 (86.4)	0.06
Complication during hospitalization (n (%))
Surgical procedures during admission	28 (19.6)	10 (16.9)	0.66
ICU stay	6 (4.2)	3 (5.1)	0.78
Nosocomial infection	6 (4.2)	2 (3.4)	0.79
Venous thromboembolism	1 (0.7)	1 (1.7)	0.52
Length of hospitalization (day, median (IQR))	4 (2-6)	4 (2-8)	0.84
Follow-up after hospitalization (n (%))
Mention of follow-up with PCP in discharge summary/nurse note	71 (49.7)	32 (54.2)	0.55
Follow-up with PCP clinic within 90 days	74 (51.7)	16 (27.1)	0.001
Mention of follow-up with GI in discharge summary/nurse note	67 (46.9)	31 (52.5)	0.46
Follow-up in GI clinic within 90 days	67 (46.9)	18 (30.5)	0.03

IBD inflammatory bowel disease, IQR interquartile range, PCP primary care physician, TNF tumor necrosis factor, ICU Intensive care unit, GI gastroenterologist